Long-Term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164 - Related Studies

Long-Term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164

This study is ongoing, but not recruiting participants.

Study NCT00650104. Last updated on October 15, 2008. Information provided by GlaxoSmithKline

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Parkinson's Disease

2	Additional conditions recognized in this trial
		Parkinson Disease

3	More general conditions related to this trial
		Basal Ganglia Diseases
		Brain Diseases
		Central Nervous System Diseases
		Movement Disorders
		Nervous System Diseases
		Neurodegenerative Diseases
		Parkinsonian Disorders

4	Interventions listed in this trial
		Ropinirole XL (formerly CR)

5	Additional drug interventions recognized in this trial
		Ropinirole

6	More general drug interventions related to this trial
		Anti-Dyskinesia Agents
		Antiparkinson Agents
		Central Nervous System Agents
		Dopamine Agents
		Dopamine Agonists
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		GlaxoSmithKline